(1888PressRelease)
January 14, 2009 - Thailand is known as the leader in medical tourism in Asia and boasts world class hospitals. Hospitals such as Bangkok Hospital and Bumrungrad are accredited by the Joint Commission International Accreditation or JCIA. Their patients travel from around the world for healthcare at a fraction of the cost but with international standards.
"We are proud to be affiliated and support the Queen Sirikit Breast Cancer Foundation here in Thailand in raising awareness at this event," said Brian Dardzinski, CEO of RMI. The staff was also in attendance and participated in the event. "Breast cancer affects all walks of life and as an American with Thai roots, it is good to see the message is spreading around the world," added RMI’s Business Director Martin Weeks.
The event is held every year at Lumpini Park in Bangkok. For more information on activities and the latest on news please visit www.returninghope.com or www.queensirikitcentreforbreastcancer.com.
Breast cancer is a cancer that starts in the cells of the breast in women and men. Worldwide, breast cancer is the second most common type of cancer after lung cancer and the fifth most common cause of cancer deaths. In 2005, breast cancer caused 502,000 deaths worldwide.
Women in the United States have the highest incidence rates of breast cancer in the world. In 2007, breast cancer was expected to cause 40,910 deaths in the US.
Breast cancer screening is an attempt to find unsuspected cancers. The most common screening methods are self and clinical breast exams, x-ray mammography, and breast Magnetic Resonance Imaging (MRI). Genetic testing may also be used.
About Regenerative Medicine International
Regenerative Medicine International is dedicated to helping early stage stem cell technology companies commercialize in the Asian market. With offices in Hong Kong and Bangkok, Thailand, RMI and its staff assist hospitals and doctors with Regenerative Medicine Technologies aimed directly at improving the lives of patients. RMI works with premier hospital and clinics in the Asian region to assist in marketing and distribution of cellular medicine. The company also provides a patient portal http://www.returninghope.com/index.html?DCSext.dept=2&WT.mc_id=100239, to act as resource for people seeking stem cell therapy anywhere in the world.
###
